1. Home
  2. SNSE vs CLRO Comparison

SNSE vs CLRO Comparison

Compare SNSE & CLRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNSE
  • CLRO
  • Stock Information
  • Founded
  • SNSE 2005
  • CLRO 1983
  • Country
  • SNSE United States
  • CLRO United States
  • Employees
  • SNSE N/A
  • CLRO N/A
  • Industry
  • SNSE Biotechnology: Pharmaceutical Preparations
  • CLRO Radio And Television Broadcasting And Communications Equipment
  • Sector
  • SNSE Health Care
  • CLRO Technology
  • Exchange
  • SNSE Nasdaq
  • CLRO Nasdaq
  • Market Cap
  • SNSE 11.2M
  • CLRO 9.3M
  • IPO Year
  • SNSE 2021
  • CLRO N/A
  • Fundamental
  • Price
  • SNSE $11.13
  • CLRO $5.89
  • Analyst Decision
  • SNSE Strong Buy
  • CLRO
  • Analyst Count
  • SNSE 4
  • CLRO 0
  • Target Price
  • SNSE $72.50
  • CLRO N/A
  • AVG Volume (30 Days)
  • SNSE 3.5K
  • CLRO 53.1K
  • Earning Date
  • SNSE 11-13-2025
  • CLRO 11-14-2025
  • Dividend Yield
  • SNSE N/A
  • CLRO N/A
  • EPS Growth
  • SNSE N/A
  • CLRO N/A
  • EPS
  • SNSE N/A
  • CLRO N/A
  • Revenue
  • SNSE N/A
  • CLRO $9,689,000.00
  • Revenue This Year
  • SNSE N/A
  • CLRO N/A
  • Revenue Next Year
  • SNSE N/A
  • CLRO N/A
  • P/E Ratio
  • SNSE N/A
  • CLRO N/A
  • Revenue Growth
  • SNSE N/A
  • CLRO N/A
  • 52 Week Low
  • SNSE $5.00
  • CLRO $3.83
  • 52 Week High
  • SNSE $17.40
  • CLRO $21.00
  • Technical
  • Relative Strength Index (RSI)
  • SNSE 71.14
  • CLRO 64.15
  • Support Level
  • SNSE $9.35
  • CLRO $5.53
  • Resistance Level
  • SNSE $10.00
  • CLRO $6.14
  • Average True Range (ATR)
  • SNSE 0.51
  • CLRO 0.46
  • MACD
  • SNSE 0.09
  • CLRO 0.07
  • Stochastic Oscillator
  • SNSE 94.27
  • CLRO 49.44

About SNSE Sensei Biotherapeutics Inc.

Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).

About CLRO ClearOne Inc. (DE)

ClearOne Inc is a communications solutions company, which is engaged in designing, developing, and selling conferencing, collaboration, streaming, and digital signage solutions for audio, video, and visual communication. It sells its commercial products to end-users predominantly through a network of independent distributors, who in turn sell its products to dealers, systems integrators, and other resellers. Its products include DSP mixers, amplifiers, Video walls, professional cameras, and professional microphones among others. Geographically the firm has its business presence across the United States and international markets.

Share on Social Networks: